News
The Food and Drug Administration has cleared diabetes-management firm DexCom's new continuous glucose monitoring (CGM) system.
The U.S. Food and Drug Administration approved DexCom, Inc.’s (NASDAQ:DXCM) Dexcom G7 15-Day Continuous Glucose Monitoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback